Regulation of the phd/doc toxin-antitoxin operon involves the toxin Doc as co-or derepressor depending on the ratio between Phd and Doc, a phenomenon known as conditional cooperativity. The mechanism underlying this observed behavior is not understood. Here we show that monomeric Doc engages two Phd dimers on two unrelated binding sites. The binding of Doc to the intrinsically disordered C-terminal domain of Phd structures its N-terminal DNA-binding domain, illustrating allosteric coupling between highly disordered and highly unstable domains. This allosteric effect also couples Doc neutralization to the conditional regulation of transcription. In this way, higher levels of Doc tighten repression up to a point where the accumulation of toxin triggers the production of Phd to counteract its action. Our experiments provide the basis for understanding the mechanism of conditional cooperative regulation of transcription typical of toxin-antitoxin modules. This model may be applicable for the regulation of other biological systems.
INTRODUCTION
Regulation of gene expression is a fundamental process that allows a cell to respond to changes in its environment. At the molecular level, expression is tuned by the concerted action of both activators and repressors, whose activities are typically linked to internal or external stimuli (Lawrence, 2003) . Bacterial toxin-antitoxin (TA) operons form small regulatory networks that are repressed under unrestrained growth conditions and activated during episodes of nutritional stress (Buts et al., 2005; Gerdes et al., 2005) . The phd/doc antitoxin-toxin operon from bacteriophage P1 contributes to the perpetuation of the plasmid-prophage inside E. coli. The toxin Doc inhibits translation by blocking the ribosomal A site (Liu et al., 2008) . This potentially lethal activity of Doc is controlled by the action of its antitoxin Phd. The C-terminal domain of Phd is intrinsically disordered in solution and folds into an a helix upon binding to Doc (Garcia-Pino et al., 2008) . The N-terminal domain of Phd is a dimerization domain that binds to DNA and represses the transcription of the operon.
A hallmark of TA operons is autoregulation of transcription by the gene products (Gerdes et al., 2005) . The molecular mechanism for the regulation of these TA modules remains elusive. Because of its short in vivo half-life, the antitoxin population must be continuously restored to prevent activation of the toxin (Gerdes et al., 2005) . Both events, the increase in the levels of free toxin and the increment in antitoxin production, are linked through the dual behavior of the toxin as a transcription enhancer/corepressor, depending on the molar ratio over the antitoxin, an unexplained phenomenon termed conditional cooperativity (Afif et al., 2001; Magnuson and Yarmolinsky, 1998; Overgaard et al., 2008) .
The apparent simplicity of the three-component network formed by toxin, antitoxin, and their operator DNA contrasts with the complex set of interactions underlying proper functioning of TA modules. To gain insights into this regulatory process we determined the crystal structure of the unbound antitoxin Phd and its complex with the toxin Doc from the phd/doc TA module of bacteriophage P1 (Lehnherr et al., 1993) . These structures provide a framework to understand how Phd/Doc complexes of variable stoichiometry can be formed and how modulation of the Phd:Doc stoichiometry affects DNA binding and repression.
RESULTS

The Phd N-Terminal Domain Adopts Two Different Folding States
Phd crystallizes in two different crystal forms. Form I contains a version of the protein that is truncated at Ser58 (hereafter termed Phd ). All four molecules in the asymmetric unit adopt a similar, well-folded conformation encompassing Met1-Phe56. This N-terminal domain forms a small globular homodimer comprising a central six-stranded b sheet decorated with four a helices (two from each monomer), resembling the antitoxin YefM (Kamada and Hanaoka, 2005) (Figure 1A ; Figure S1A available online). The N-terminal a helices a1 and a2 form a large positively charged surface that constitutes the DNA-binding region ( Figure S1B ). The dimer interface is relatively small (about 900 Å 2 of water accessible surface buried per dimer). Interaction of b strands b3 (Ala36-Ser40) from both monomers with each other and with helices a1 and a2 accounts for most of the hydrophobic core of the protein, which runs through the dimer interface and consists only of a number of small aliphatic side chains. A rather unusual feature of the Phd hydrophobic core is the presence of a relatively large cavity (about 210 Å 3 , Figure 1A ).
At the C termini of strand b3, a third set of a helixes emerges that connects the N-terminal domain to the intrinsically disordered C-terminal region. The a helices a3 from both monomers cross at an angle of about 60
, creating a second small hydrophobic core distinct from the main hydrophobic core of the N-terminal domain. This arrangement, with Phe44 shielded by Tyr47 and an intermolecular salt bridge formed between Glu25 of one monomer and Lys48 of the other ( Figure S1C ) is likely to further stabilize the Phd dimer.
Crystal form II on the other hand contains two distinct conformations of full-length Phd entrapped in the same single crystal lattice. The first conformation is highly ordered, with the N-terminal domain having a conformation essentially indistinguishable from the one observed in crystal form I. The C-terminal domain (Ala57-Arg73) of this dimer is also structured due to lattice interactions ( Figure 1B ; Figure S1D ). The conformations adopted by the C terminus are distinct from each other and from the Doc-bound conformations (see below). They contain variable amounts of a helix and likely sample the conformational ensemble of the Phd C-terminal domain in solution.
The second conformation observed in crystal form II is a partially unfolded one ( Figure 1C ). Whereas the b sheet core remains essentially intact (with b strands b1, b2, and b3 as the sole elements of regular secondary structure), the surrounding a helices almost completely unwind ( Figure 1C ). The residues from a helix a1 become disordered whereas those originating from a helix a2 adopt a loop conformation. Residues belonging to helices a1 and a2 are likely to constitute the operator binding (E) Variation of the R 2 /R 1 ratios with the residue number for the Phd ensemble in solution (red bars) and those calculated for the folded conformation based on the crystal structure (represented as gray bars). The secondary structure elements of the N-terminal domain as observed in the crystal structure, are show as an inset.
(F) Mapping of the backbone 15 N relaxation data on the structure of Phd . The ''dynamic hot spots'' involved in conformational exchange (based on the R 2 /R 1 data) are colored in red, and the regions involved in fast dynamics (based on the heteronuclear NOE data) are colored in purple. See also Figure S1 and Table S1. site as mutations that change operator DNA specificity map in this region (Zhao and Magnuson, 2005) . Therefore the partially unstructured conformation of Phd is probably not capable of binding to the phd/doc operator site. Indeed, a helix is induced in Phd upon addition of operator DNA in vitro (Figure 2A ).
Phd Adopts a Heterogeneous Conformational Ensemble in Solution
To further understand the nature of the Phd conformational ensemble in solution, we used small-angle X-ray scattering (SAXS) and nuclear magnetic resonance (NMR). Analysis of the SAXS data strongly suggests the presence of conformational heterogeneity in solution. The plateau at I(s)s 2 > 0 observed in the Kratky plot ( Figure 1D ) indicates that Phd is partially unstructured (Pollack et al., 1999; Porod, 1982) , in agreement with earlier circular dichroism (CD) studies (Gazit and Sauer, 1999) . The disorder indicated by the SAXS data is consistent with the high flexibility of Phd in the crystal. However, the theoretical scattering curve computed from both types of dimer (ordered or disordered) observed in the crystal structures is insufficient to fit the experimental SAXS data ( Figure 1D ). Intrinsic disorder of the C-terminal domain is a main contributor to protein heterogeneity as determined by SAXS. Using the ensemble optimization method (EOM) (Bernado et al., 2007) , we find that the scattering curve can be modeled assuming a fixed conformation for residues 1-40 of Phd and a wide structural ensemble for residues 41-73 (c 2 = 0.8, Figure 1D , Table S1 ). Thus the conformational heterogeneity observed in the N-terminal domain does not significantly affect its overall shape. A subset of the selected ensemble illustrating the structural diversity of the population is shown in Figure S1E . This ensemble is consistent with the lack of secondary structure previously observed in the CD spectrum of the C-terminal domain of Phd (Garcia-Pino et al., 2008) .
We used NMR to characterize the structure of the N-terminal domain of Phd (Phd 1-57 -residues 1-57) in solution. This N-terminal domain of Phd examined by two-dimensional (2D) 1 H-15 N HSQC NMR is in agreement with a conformationally heterogeneous protein that populates folded and disordered states ( Figure S1F , in cyan). However, at low ionic strength, the protein is stabilized in a state that allows the assignment of the 1 H-15 N cross-peaks ( Figure S1F , in blue).
When attempting to probe the flexibility of Phd 1-57 with hydrogen-deuterium exchange experiments, virtually all amide protons exchange within the set-up time (11 min) prior to the start of NMR acquisition, and their 1 H-15 N cross-peaks are therefore absent in the HSQC spectrum. Such dramatic behavior indicates very low stability and lack of conformational rigidity and is presumably the result of a high overall conformational exchange of Phd between folded and partially folded states (See Extended Experimental Procedures for further details).
In order to better characterize the dynamics of the N-terminal domain of Phd, we next measured 15 N backbone relaxation rates. The heteronuclear Nuclear Overhauser Effect values (hNOE), probing extensive high-frequency motions on the ps to sub ns timescale, are almost all lower than the minimal value of 0.86 at 800 MHz expected for a rigid globular protein ( Figure S1G ). See also Figure S2 , Table S2 , and Figure 1E shows the R 2 /R 1 ratios along the Phd 1-57 sequence (represented as red bars). Two regions show significantly high R 2 /R 1 ratios as a result of elevated R 2 rates, indicative of a pronounced conformational freedom and high exchange between different conformational states in the ms to ms timescale. Additionally the C-terminal region displays pronounced low R 2 /R 1 ratios, which indicate an increase in fast dynamics (i.e., high degree of flexibility) in agreement with the heteronuclear NOE values found for this region of the domain ( Figure S1G ). More significantly, when we map the R 2 /R 1 data on the X-ray structure of Phd ( Figure 1F ), the ''dynamic hot spots'' correspond to a helices a2 and a3, two regions that lose structure in the partially disordered conformation observed in the X-ray structure.
The dynamic nature of Phd 1-57 in solution becomes even more apparent when we compare the experimentally determined R 2 / R 1 ratios for the Phd 1-57 solution ensemble with those calculated theoretically using the coordinates of the crystal structure of the folded protein ( Figure 1E ). In the folded conformation the predicted R 2 /R 1 pattern is significantly more uniform throughout the entire domain and the values for a helices a2 and a3 are close to the average. By contrast the solution ensemble contains ''dynamic hot spots'' that are involved in significant conformational exchange, and the C-terminal region (a helix a3 in the folded conformation) is disordered. Only the b sheet core of the protein retains a more folded behavior, exactly as we observed in the crystal structure of the partly folded species ( Figures 1C and 1F ).
Operator DNA and Doc Binding Lead to Structuring of Phd Differential scanning calorimetry (DSC) unfolding data of Phd and its N-terminal fragment Phd 1-57 fit well to a two-state model consisting of a dimer unfolding into monomer species. In its unbound state Phd is only marginally stable ( Figure 2B ). The unfolding endotherms of both the full-length protein and the deletion mutant Phd 1-57 are virtually identical and characterized by marked broadening and very low heat of denaturation (Figures S2A-S2B and Table S2 ). This indicates a poorly structured unfolding unit, suggesting that, in agreement with the NMR data, the partly unfolded species dominates in solution. In addition, the sizable cavity in the hydrophobic core of the folded state of the N-terminal domain is expected to contribute to its low thermodynamic stability.
Earlier studies indicated that operator DNA binding increases the melting temperatures of several TA antitoxins (Gazit and Sauer, 1999; Madl et al., 2006; Oberer et al., 2007) . Our DSC measurements show that binding of DNA or of its toxin partner Doc to Phd significantly increases its thermodynamic stability ( Figure 2B , Figure S2C , and Table S2 ). In both cases the increment in the conformational stability is accompanied by a large increase in the heat of unfolding and the melting temperature of Phd. Both binding events also coincide with an increase in a-helical content as observed by CD spectroscopy for the Phd-operator DNA complex ( Figure 2A ) and by X-ray crystallography and SAXS for the Phd/Doc complexes (see below). These results support our conclusion that the population ensemble equilibrium shifts toward a more ordered conformation of the N-terminal domain upon binding, coupling stabilization to the increment of the repression-compatible subpopulation of Phd.
The Secondary Hydrophobic Core of Phd Affects DNA Binding Mutations within a helix a3 in the central region of Phd strongly affect DNA binding. Whereas the wild-type dimer clearly occupies two binding sites consecutively ( Figure 3A ), the F44A, Y47A, and K48M mutants show a significant reduction of DNAbinding capacity in vitro ( Figure S3A ). Phd F44A and Phd
Y47A
were also shown to affect the repressor activity of Phd in vivo (McKinley and Magnuson, 2005 and Table S3 ). As the region of Phd harboring these residues is unlikely to come in direct contact with DNA, the mutations are expected to act through a global destabilization of the protein by disturbing the small secondary hydrophobic core of Phd. Indeed, CD spectra of these mutants indicate that they are significantly less structured than the wildtype protein ( Figure S3B ). In contrast, all Phd mutants retain their ability to bind and inhibit Doc ( Figure 3C ). Wild-type Phd fully inhibits the effect of Doc on translation of the mRNA encoding E. coli EF-Tu when present at a 1:1 ratio to Doc. The effects of Phd mutants F44A, Y47A, and K48M on in vitro translation of EF-Tu are indistinguishable from that of the wild-type protein. The latter is not surprising as all mutations are located outside the Doc-interacting segment of Phd and as the C-terminal segment (residues 50-73) on its own is sufficient for inhibiting Doc activity in vitro and in vivo (McKinley and Magnuson, 2005; Smith and Magnuson, 2004) .
Thus the formation and stabilization of the small hydrophobic core of Phd has a pivotal role in the exchange between unbound and DNA-bound conformations. The stabilization of this structure tilts the equilibrium in the direction of the folded (DNAbinding compatible) state, whereas mutations destabilizing a helix a3 shift the equilibrium toward the disordered low-DNA affinity state.
Long-Range Allosteric Interactions Couple Toxin
Binding to Operon Regulation Doc-mediated enhancement of Phd binding to operator DNA is observed in operator regions containing a single Phd-binding site ( Figures 3D-3F ), in agreement with earlier observations (Magnuson and Yarmolinsky, 1998) . The effect of Doc on the affinity of Phd for a single DNA-binding site (O R1 ) was quantified using isothermal titration calorimetry (ITC). The affinity of Phd 2 Doc for O R1 is 0.3 mM, about 10-fold higher than the binding constant of Phd 2 for O R1 (Figures 3D and 3E ; Table S4 ). Thus binding of Doc to the intrinsically disordered C-terminal region of Phd allosterically affects the activity of the N-terminal binding domain. Allosteric coupling involving disordered domains has been hypothesized before (Hilser and Thompson, 2007) but never observed experimentally.
Given that helix a3 of Phd is located adjacent to its Doc-binding region and that mutations within this helix affect operator DNA binding in vivo and in vitro, we investigated if such mutants would also affect Doc-mediated enhancement of the Phd-operator DNA affinity. Phd mutants F44A and Y47A bind to Doc, but this does not lead to an increase of the affinity of the Phd mutant for O R1 ( Figure 3F ), indicating disruption of the communication between the N-and C-terminal domains of Phd. Thus these mutations uncouple the Doc-binding and operator DNA-binding activities of Phd and pinpoint helix a3 of Phd as a communication channel between its N-and C-terminal domains.
Phd mutant K48M on the other hand shows an intermediate behavior in terms of Doc binding and the corresponding enhancement in DNA binding. Despite its low intrinsic affinity for DNA, which is similar to Phd F44A and Phd
Y47A
, this mutant shows weak but observable enhancement of Phd 2 binding to O R1 in the presence of Doc ( Figure 3F ), indicating that the effects observed for Phd F44A and Phd Y47A are not a consequence of their weak DNA binding potential per se.
Doc Possesses Two Nonidentical Binding Sites for Phd
The asymmetric unit of our Phd/Doc cocrystals contains three copies of Phd and one copy of Doc, which through crystal symmetry form a hetero-octameric Phd 2 -Doc-Phd 2 -Doc-Phd 2 complex ( Figure 4A ; Figure S4A ). Alternating units of toxin and antitoxin molecules bound to DNA were predicted from biochemical data for the ccd operon (Dao-Thi et al., 2002) and have been observed using native mass spectrometry experiments in the mazEF module . The architecture of the Phd/Doc complex, however, is quite unique. A monomeric Doc toxin possesses two binding sites (termed H and L hereafter) that recognize the Phd C-terminal segment in distinct conformations, thereby bridging two antitoxin dimers.
About 25% of the surface of Doc is buried upon interacting with two Phd dimers ( Figure 4B ). Site H corresponds to the one identified earlier in the crystal structure of a nontoxic mutant of Doc (Garcia-Pino et al., 2008) and recognizes the Phd segment Phe56-Arg73. This site encompasses residues from a helices a1, a4, a5, and the loop a4-a5 of Doc ( Figure 4B ) and represents the most extensive contact interface between toxin and antitoxin (1024 Å 2 are buried). Site L is located on the opposite side of Doc ( Figure 4B ) and mainly encompasses residues from loops a1-a2 (residues 28-31) and a5-a6 (residues106-111) and from helices a2 (34-35, 38-39, 42) and a3 (57-61, 64-65) . This site forms a shallow hydrophobic indentation on the surface of the protein and accommodates residues Leu52-Thr62 of Phd in an a-helical conformation. The side chains of Leu52, Phe56, Leu59, and Phe60 of Phd provide the most extensive contacts to Doc. This binding surface on Doc is fenced by the charged residues Asp28, Arg31, Arg38, Arg42, and Arg64. This ''electro-positive fence'' interacts with the hydrophilic part of the amphipathic C terminus of Phd, tethering the Phd C-terminal a helix to the surface. The total area buried upon complex formation (650 Å 2 ) is much smaller, resulting in marked differences in affinities between both sites. , Phd Y47A , and Phd K48M with a DNA fragment containing one binding site (O R1 ). Phd was used at 50 nM whereas the mutants were used at 1 mM. In all cases Doc was added in equimolar amounts. The labels C, P, and F are as in (B).
Further details are given in Figure S3 , Table S3, and Table S4 .
The distance between two equivalent residues from the Docbridged Phd dimers is approximately 43 Å (Figure 4A ), matching the separation of equivalent bases of the two palindromes of the phd/doc operator region recognized by Phd (assuming B-DNA). This suggests that the conformation of the complex observed in the crystal structure closely resembles the one that binds on the promoter region and represses the transcription of the phd/doc operon.
Using surface plasmon resonance (SPR), we measured the binding kinetics and affinities for both interaction modes between Phd and Doc ( Figure 2C ). Consistent with the crystal structure of the complex, the best model that explains the binding data involves two Phd dimers binding to a Doc monomer with affinities of 0.35 mM and 31 mM ( Figure 2C ; Table S4 ). These features were further confirmed by ITC measurements ( Figure 2D and . The affinities obtained for the mutants pinpoint site H as the high-affinity site and site L as the lowaffinity site, in agreement with their difference in contact surface area.
Phd and Doc Form a Series of Distinct Complexes
When Bound to Operator DNA Doc modulates the affinity of Phd for the operator region of the operon as observed in electrophoretic mobility shift assays ( Figure 3B ). At increasing Doc:Phd ratios between 0 and 1, the band corresponding to unbound DNA disappears and a series of distinct bands appear that we interpret in terms of Phd/Doc/ DNA complexes of variable stoichiometry. A first Doc molecule will bridge the two Phd dimers bound to their two sites on the operator DNA and increase affinity through an avidity effect. This interaction will recruit both the high-and low-affinity sites on Doc. A second and third Doc molecule will bind through their high-affinity sites on the two free Phd C termini of the DNAbound Phd 2 -Doc-Phd 2 complex, resulting in a Doc-Phd 2 -DocPhd 2 -Doc operator DNA complex.
Additional molecules of Doc, however, cannot interact without disturbing this repressor complex. Indeed, when the Doc:Phd ratio exceeds 1, the operator complexes apparently resolve. The remaining affinity for what is probably a Doc-Phd 2 -Doc complex interacting only via the H sites drops to a level comparable to that of Phd in absence of Doc.
When tested on the full operator region (O R1/2 ), the two Phd mutants Phd F44A and Phd Y47A that lack allosteric coupling between their N-and C-terminal domains create in the presence of Doc a similar series of distinct DNA complexes as observed for wild-type Phd ( Figure S3C ). The enhancement in affinity due to bridging of Doc is nevertheless much weaker than what is observed for wild-type Phd, indicating the importance of the communication between both Phd domains for autoregulation and an interplay between the allostery and avidity effects of Doc. Derepression at high Doc to Phd ratios does not seem to be affected by these mutations.
Both Phd-Binding Sites on Doc Are Essential for the Autorepression In order to validate the role of both Phd-binding regions on Doc, we designed point mutants individually affecting the two binding sites of Doc and analyzed their behavior in vivo and in vitro. As mutations in one or both of the binding sites may lead to uncontrolled toxicity of Doc, these experiments were carried out in a nontoxic Doc H66Y background to facilitate the production of See also Figure S4 and Table S1 .
the proteins. The mutation H66Y in Doc does not affect the structure of the protein (Garcia-Pino et al., 2008) nor Phd binding (Table S4) . Furthermore, wild-type and Doc H66Y show indistinguishable patterns of band-shifting in our EMSA assay, indicating that both proteins enhance the Phd-DNA interaction in an identical manner ( Figure 3B and Figure 5A ).
The N78W mutation was selected to knock out site H whereas A61R was chosen to knock out site L. These mutations are located on the surface of Doc and do not affect the overall structure of the protein as assessed by CD spectroscopy ( Figure S3D ). Their Phd-binding activities were confirmed using ITC ( Figure 2D-see above) . Both mutants show a less complex set of bands in EMSA experiments in agreement with the presence of only one functional site, indicating that both sites are indeed recruited in the wild-type operator complex but not in the mutant complexes ( Figure 5A ).
We further validated the role of site L in autoregulation (again in a nontoxic Doc H66Y background) in vivo using a lacZ repression assay and through an indirect toxicity assay that reports the presence of a functional site H (see Extended Experimental Procedures for details). Knocking out site L is expected to result in a Doc phenotype unable to act as corepressor but still capable of binding Phd through site H. As expected, most mutants (R31A, R31D, I35A, R38A, R38D, A61W, A61D, R64E, and R64W) show a decreased corepression activity ( Figure 5B ; Table S5 ), remaining, however, capable of displacing wild-type Doc from site H. This effect is severely marked for the mutants R38D and A61D (in agreement with our in vitro results). These site L mutants disrupt the interaction of Phd with Asp53 (in the case of the R38D mutation) or introduce a negative charge in the hydrophobic pocket that accommodates residues Phe56 and Phe60 of Phd (for A61D) and results in a complete loss of corepression. However, their ability to bind Phd through their H site remains intact ( Figure 5C ; Table S5 ). Thus the low-affinity interaction that is required to establish a Doc-bridge between two operator-bound Phd dimers is crucial for Doc-mediated enhancement of repression.
Solution Structure of the Doc-Phd 2 -Doc Complex Our mechanistic model for conditional cooperativity predicts that at saturating levels of Doc, a Doc-Phd 2 -Doc heterotetrameric complex that is far less capable of repressing the phd/doc Table S5. operon is formed. We used SAXS to characterize this complex and examine its shape and dimensions. Based on our crystal structure, we constructed a series of alternative Phd/Doc complexes with different stoichiometries (including Phd 2 -DocPhd 2 , Doc-Phd 2 -Doc, and the two possible Phd 2 -Doc architectures). The comparison of the experimental scattering data to the calculated scattering curves derived from these models reveals a close correspondence only to the Doc-Phd 2 -Doc model and very poor fits to other architectures (Table S1 ). The Rg (27.5 Å ) calculated from the Guinier analysis and the bimodal shape and maximum dimension of the particle (Dmax = 85 Å ) obtained from the distance distribution function (P(r)) all agree with our V-shaped model of the Doc-Phd 2 -Doc complex. Moreover the P(r) function and Kratky plot are consistent with a properly folded, homogeneous, and well-structured species ( Figures  S4B-S4C ).
To provide additional support to the models obtained by rigid body fit, we used the program DAMMIF for ab initio SAXS shape reconstruction of the complex. No constraints were imposed on the simulated annealing refinement protocol. All the models were very reproducible in independent runs with average normalized spatial discrepancy (NSD) values below 1.0. These models are highly consistent with our pseudo-atomic model of the complex and show the same V-shaped structure ( Figure 4C) . Docking of our pseudo-atomic model on the phd/doc operator site shows that two Doc-Phd 2 -Doc entities cannot bind simultaneously to the two operator sites due to steric overlap. Thus steric exclusion provides the mechanism for derepression at high Doc:Phd ratios.
A Model for the Regulation of the Phd/Doc Operon Our combined structural and biochemical data allow us to put forward for the regulation of the phd/doc operon a model that explains conditional cooperativity (Figure 6 ). We propose that a monomeric Doc molecule, capable of interacting with two Phd dimers simultaneously, acts as a bridge between two Phd dimers, increasing the avidity of Phd for DNA and thus enhancing the repression of the operon.
In this arrangement, both the H and L sites of Doc are occupied and both Phd dimers retain a free toxin-binding site. These free sites will act as buffers that can trap additional Doc molecules through their H sites. Further increase in the ratio of Doc to Phd will ultimately outcompete the low-affinity L sites of Doc in favor of the high-affinity H sites, resolving the repressor complex. The resulting alternative nonrepressing Doc-Phd 2 -Doc complex is a rigid entity that for steric reasons cannot occupy both sites on the operator DNA. Therefore high Doc:Phd ratios, which are dangerous for the cell, will result in transcription of the operon and production of Phd, after which repression is again established. Only in the case where the P1 plasmid is lost will the proteolytic degradation of Phd release Doc in sufficient amounts to block translation indefinitely by binding to the A site of the ribosome and cause cell death.
Additional cooperativity in the system arises from prestructuring of the DNA-binding domain of Phd by binding of Doc units. The crystal and solution structures of Phd suggest the coexistence in solution of a partially disordered Phd dimer ensemble in equilibrium with a more ordered, DNA-binding-competent population. The addition of Doc shifts this equilibrium toward the DNA-competent conformation, increasing the affinity of the Phd for its operator DNA.
Thus the system relies on intrinsic disorder not only to allow Phd to bind to two distinct sites on Doc but also to modulate the intrinsic affinity of Phd for its operator DNA and to separate the neutralization function of Phd from its regulatory function. The high-affinity site safeguards the cell from the action of free toxin whereas the low-affinity site is essential for the cooperative binding to DNA and for switching from repression to derepression.
DISCUSSION Allosteric Coupling and Intrinsic Disorder
Allostery is an essential part of many if not most nonstructural proteins, and in particular of regulatory proteins. A second general feature of regulatory proteins, especially in eukaryotes, is the prevalence of intrinsic disorder. A link between both properties has been suspected and a theoretical framework Two additional Doc molecules can bind to this complex via the two remaining free C termini of Phd. A fourth molecule of Doc, however, will resolve the operator complex by exchanging an L site interaction by an H site interaction, resulting in derepression. Proteolytic degradation of Phd under activating conditions such as nutritional stress will free Doc and allow it to bind to the A site of the ribosome to inhibit translation. Fresh Phd can rescue the ribosome and the resulting complex will again repress the phd/doc operon. See also Figure S5 . explaining how intrinsic disorder can increase allosteric coupling between two contacting domains has been proposed (Hilser and Thompson, 2007) . Our studies on Phd provide direct experimental evidence demonstrating allosteric coupling between two domains displaying different degrees of disorder. The N-terminal domain of Phd exists in solution as an equilibrium between a DNA-binding-competent ordered state and a DNAbinding-incompetent, highly unstable state. The equilibrium between both states is influenced not only by its direct ligand, the operator site, but also by binding of the Doc corepressor to the intrinsically disordered C-terminal segment of Phd.
It was predicted that site-to-site coupling would be maximized when a well-defined pathway of folded structure connects the two sites (Hilser and Thompson, 2007) . Such a pathway is indeed present within Phd and involves a set of specific interactions at the boundary between both communicating domains. Binding of Doc to the C-terminal segment of Phd results in the formation of an a helix that extends into helix a3 of its N-terminal domain. In this way, a3 is stabilized and this stabilization propagates through the small hydrophobic core of the protein over the whole N-terminal domain including the DNA-binding site.
A query of the Protein Data Bank (PDB) revealed three additional proteins that adopt a similar fold: E. coli YefM, the N-terminal domain of M. tuberculosis YefM, and an N-terminal fragment of a transcriptional regulator from N. europaea (Kamada and Hanaoka, 2005; Kumar et al., 2008) . All these proteins show a well-conserved fold despite very little sequence identity. The two key structural features of the linking region that mediates allosteric communication in Phd are nevertheless present in each of them: a small hydrophobic core typically shielded by two aromatic side chains contributed by each helix a3 and a network of salt bridges that tethers N-and C-terminal domains ( Figure S5 ). This observation validates this structural motif as functionally relevant and suggests a general stabilitybased allosteric switch for the members of the Phd/YefM superfamily.
Intrinsic Disorder in a Prokaryotic Transcription Regulator
Much of the knowledge we have about regulation of transcription in prokaryotes comes from two particularly well-studied systems: the Lac repressor-lac operon (Lewis et al., 1996) and the l-repressor and l-Cro for the control of the lysogenic/lytic cycles of l-phage (Albright and Matthews, 1998) . In both cases, the repressors are well-folded species lacking appreciable structural disorder. Eukaryotic transcription factors on the other hand are characterized by frequently possessing intrinsically disordered segments or domains (Liu et al., 2006) . Intrinsic disorder, however, can be detected in the genomes of prokaryotes as well, but its functional relevance is less well understood (Dunker et al., 2002; Tompa, 2002) . The insights obtained on the regulation of the phd/doc operon pinpoint a mechanism by which intrinsic disorder functions in prokaryotes and provide one of the few mechanistic studies on intrinsic disorder in general.
A major discovery of this study is that the antitoxin Phd binds to two different sites of a single Doc monomer through its intrinsically disordered C terminus. These interactions show a 100-fold difference in affinity, allowing both the H and the L sites on Doc to be occupied at high Phd:Doc ratios but the lower affinity L site to be outcompeted at low Phd:Doc ratios. This property is the core of regulation by conditional cooperativity, which is general in toxin-antitoxin modules (Afif et al., 2001; Magnuson and Yarmolinsky, 1998; Monti et al., 2007; Overgaard et al., 2008) . Transcription of TA operons is conditional to the ratio between toxin and antitoxin and provides the cells with a homeostatic mechanism to sense and respond to oscillating levels of toxin. In absence of toxin, the antitoxin is only a weak repressor and transcription of the operon occurs. At toxin:antitoxin ratios below 1, a repressing complex is formed by the bridging of a toxin between two antitoxin proteins. The resulting increase in affinity of the antitoxin for its operator DNA through avidity is further enhanced by the structuring effect that the toxin exerts on the DNA-binding domain of the antitoxin. At higher toxin:antitoxin ratios, derepression occurs through a switch from a low-affinity toxin-antitoxin interaction to a high-affinity interaction, resulting in a complex with a different architecture (Doc-Phd 2 -Doc) that is unable to efficiently repress the operon.
This mechanism of transcriptional control integrates intrinsic disorder as a cornerstone of the regulatory process (a feature previously considered only for eukaryotic proteins). The structural plasticity inherent to these proteins is a particular advantage in the transmission of information. Signals can be transmitted by a mere shift in the equilibrium population of states: a single protein could deliver the signal to multiple targets, turning the protein into a dynamic switch.
A General Regulatory Mechanism?
The regulatory mechanism of phd/doc is likely to be general for TA modules where conditional cooperativity seems to be a general property. Indeed, the presence of repressor complexes consisting of linear arrays of alternating antitoxin and toxin units have been hypothesized for mazEF and ccdAB (Dao-Thi et al., 2002; De Jonge et al., 2009; Monti et al., 2007) . Furthermore, the existence of toxin-antitoxin complexes with different stoichiometry has been demonstrated for both mazEF and ccdAB (De Jonge et al., 2009; Kamphuis et al., 2007) .
Similar or related mechanisms may be at work outside the TA context as well. Antitoxin DNA-binding domains belong to the ribbon-helix-helix fold, the helix-turn-helix superfamily, the AbrB superfamily, and the Phd/YefM superfamily, all well-known families of prokaryotic transcription factors (Anantharaman and Aravind, 2003) . The attachment of a regulatory module at their C termini in their TA-related versions (their toxin-binding domains) results in an additional dimension in mechanistic complexity, incorporating the toxin in the regulatory mechanism as an anti/corepressor. Such segments that link a DNA-binding protein to coregulatory elements may be present in a number of other prokaryotic transcription regulators but still await identification.
EXPERIMENTAL PROCEDURES Structure Determination and Refinement
The structure of the Phd/Doc complex was determined by molecular replacement using the coordinates of Doc H66Y (PDB ID 3 dd7) as a search model in PHASER (McCoy et al., 2005) . The structures of free Phd were determined by molecular replacement using the N-terminal domain of Phd as present in the Phd/Doc complex as search model. Refinement cycles using the maximum likelihood target function of phenix.refine (Afonine et al., 2005) were alternated with manual building using Coot (Emsley and Cowtan, 2004) . The final cycles included TLS refinement, with the optimal TLS groups calculated using the TLSMD web server (Painter and Merritt, 2006) . In every case, the final structures were validated with MolProbity (Davis et al., 2007) . The statistics of the refinement are shown in Table 1 .
Surface Plasmon Resonance
Surface plasmon resonance (SPR) experiments were carried out on a Biacore3000 system (GE Healthcare) at 25 C in 20 mM HEPES (pH 7.5), 150 mM NaCl, 3 mM EDTA, 0.005% TWEEN-20 and a flow rate of 30 ml/min. All the binding data were analyzed with the BIAevaluation 4.1 software.
Small-Angle X-Ray Scattering SAXS data for free Phd and the Doc-Phd 2 -Doc complex were collected at beamline X33 of the DESY synchrotron (Hamburg, Germany). The camera length was 2.7 m and the wavelength 1.5 Å , with 2 min of exposure time for data collection. The data were averaged, background-subtracted, and merged to generate the scattering curve with PRIMUS (Konarev et al., 2003) . The radius of gyration (Rg) was calculated from the Guinier analysis as implemented in PRIMUS and also from the entire scattering curve with the indirect Fourier transform package GNOM (Konarev et al., 2003 (Konarev et al., , 2006 . CRYSOL (Svergun et al., 1995) was used to compare experimental and theoretical scattering curves.
NMR Spectroscopy
For the backbone assignment of Phd 1-57 , a 15 N/ 13 C-labeled sample was prepared for NMR experiments at 200 mM in 92% H 2 O, 8% D 2 O, 150 mM NaCl, 0.1 M Arginine, 50 mM TRIS buffer at pH 7.5. NMR spectra were recorded on a Varian NMR Direct-Drive Systems 800 MHz spectrometer using a salt-tolerance triple-resonance cold-probe at 25 C.
Isothermal Titration Calorimetry
All measurements were performed on a MicroCal VP-ITC calorimeter. The samples were filtered and degassed for 30 min at 298 K before being examined in the calorimeter. All measurements were done at 298 K, in 20 mM Tris buffer (pH 7.5), 100 mM NaCl, and 1% glycerol. All data were analyzed using MicroCal Origin DSC 7.0.
Electromobility Shift Assays
Binding of Phd to DNA fragments from the operon regulatory region (O R1/2 and O R1 ) was followed by mobility shift electrophoresis (EMSA) as described (Gazit and Sauer, 1999; Magnuson and Yarmolinsky, 1998 
